- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00029809
Chinese Exercise Modalities in Parkinson's Disease
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The long-term goal of this project is to study the effects of different exercise modalities on Parkinson's disease (PD). PD is a disorder whose primary disability stems from motor dysfunction including balance. Recent studies have shown that the risk of falling in the elderly can be reduced through the practice of the Chinese complementary and alternative medicine (CAM) such as T'ai Chi Chuan (TCC). This finding may be highly significant to PD. Although a recent report from Emory suggests PD patients can do well with aerobic (walk-run) exercise training (AET), it is still unclear whether the potential anti-Parkinsonian effect of such modalities is secondary to improved physical fitness (CRF), motor control or both. CAM interventions such as TCC may offer a unique opportunity to examine these fundamental questions.
In PD we hypothesize that exercise training will reduce primary and secondary disability and that some of these changes represent adaptive reprogramming of central motor pathways. We will conduct a controlled double-blind, 16-week dose-response study of exercise based on caloric expenditure and thus on the cardiorespiratory fitness effects of exercise (CRF). The treatments will be Qi Gong (minimal caloric expenditure), TCC (low expenditure), and walk-cycle AET (moderate expenditure).
We will examine exercise-induced change in motor control using quantitative measures of motor disability, including dynamic gait stability measures. We will also examine exercise effects on central and peripheral indices of Parkinsonian motor disability.
A caloric "dose-response" effect of exercise would suggest CRF is a major determinant of the anti-Parkinsonian effects of exercise. If the Chinese modalities are as effective or superior to AET however, this would suggest that other mechanisms such as change in central motor programming may be playing a role (e.g. relaxation effects, reinforcement of central motor programs?). A better understanding of exercise-induced neural plasticity and motor control would offer a significant, and heretofore unexploited rehabilitative potential in PD.
Tipo di studio
Iscrizione
Fase
- Fase 2
- Fase 1
Contatti e Sedi
Luoghi di studio
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30329
- Emory University School of Medicine
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Ambulatory patients with Parkinson's Disease, defined as a clinical state in which at least two of these four cardinal features are present- 1) slowness of movement, 2) tremor at rest, 3) muscular rigidity, 4) gait disturbance or posture imbalance.
- Ambulatory patients with Parkinson's Disease not exercising regularly more than 2x per week. Willing to be randomly assigned to 1 of the 3 exercise modalities: Tai Chi, Qi Gong and Aerobic exercise.
NOTE THAT PARTICIPATION IN THE STUDY REQUIRES BI-WEEKLY PARTICIPATION IN A 16-WEEK SUPERVISED EXERCISE PROGRAM PLUS RELATED EVALUATIONS AT EMORY. ACCORDINGLY, RECRUITMENT IS LIMITED TO LOCAL PATIENTS.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
Collaboratori e investigatori
Investigatori
- Investigatore principale: Jorge L. Juncos, MD, Emory University
Studiare le date dei record
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- R01AT000612-01 (Sovvenzione/contratto NIH degli Stati Uniti)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Morbo di Parkinson
-
Bezmialem Vakif UniversityReclutamentoMorbo di Parkinson | Parkinson | Malattia di Parkinson (MdP) | MALATTIA DI PARKINSON (disturbo) | Morbo di ParkinsonTurchia (Türkiye)
-
CND Life SciencesOregon Health and Science UniversityReclutamentoMorbo di Parkinson | Parkinson | Malattia di Parkinson e parkinsonismo | MALATTIA DI PARKINSON (disturbo)Stati Uniti
-
University of LahoreCompletato
-
ProgenaBiomeRitiratoMorbo di Parkinson | Malattia Di Parkinson Con Demenza | Sindrome di Parkinson-demenza | Malattia di Parkinson 2 | Malattia di Parkinson 3 | Malattia di Parkinson 4Stati Uniti
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) e altri collaboratoriNon ancora reclutamentoMicrobiota intestinale | Microbioma intestinale | Malattia di Parkinson (MdP) | MALATTIA DI PARKINSON (disturbo) | Malattia di Parkinson ProdromicaStati Uniti
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedReclutamentoMorbo di Parkinson | Parkinson | Morbo di Parkinson idiopatico | Malattia di Parkinson, idiopatica | Malattia di Parkinson precoce (PD precoce)Stati Uniti, Spagna, Israele, Polonia, Italia, Regno Unito
-
CND Life SciencesDigestive Disease Associates of CTReclutamentoMorbo di Parkinson | Parkinson | MALATTIA DI PARKINSON (disturbo) | Morbo di ParkinsonStati Uniti
-
EicOsis Human Health Inc.University of California, Davis; Michael J. Fox Foundation for Parkinson's ResearchReclutamentoMalattia di Parkinson (MdP)Stati Uniti
-
University of Kansas Medical CenterNon ancora reclutamentoMalattia di Parkinson (MdP)Stati Uniti
-
AbbVieReclutamento